Stephen Uden, M.D.
Board Member
Rallybio Corp (RLYB)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Stephen Uden, M.D.
Stephen Uden, M.D. is recorded as CEO and Board Member at Rallybio Corp (RLYB). Rallybio Corp reported in an 8-K filed June 29, 2023 that Stephen Uden, M.D. was appointed director, effective August 1, 2023. Rallybio Corp reported in an 8-K filed June 29, 2023 that Stephen Uden, M.D. was appointed Chief Executive Officer, effective August 1, 2023.
“On June 28, 2023, the Board increased its size from ten directors to eleven directors, effective August 1, 2023, and appointed Dr. Uden to serve as a director to fill the newly created vacancy as of such date.”
“On June 28, 2023, the Board of Directors (the Board) of Rallybio Corporation (Rallybio) appointed Stephen Uden, M.D., Rallybio's President, Chief Operating Officer and Co-Founder since January 2018, to Chief Executive Officer, effective August 1, 2023.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-08-01–present
-
Current
2023-08-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Rallybio Corp
Other people whose current roles at this company are on record from its filings.
- Athena Countouriotis, M.D. CEO
- Stephen Uden CEO, COO, Board Member
- Martin Mackay, Ph.D. Chairman
- Jonathan I. Lieber CFO
- Scott Lipman, M.B.A. CFO
- Brian Sun, J.D. General Counsel
- Christine A. Nash Board Member
- Helen M. Boudreau Board Member
- Hui Liu Board Member
- Hui Liu, Ph.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.